கரோலினா சிறுநீரக ஆராய்ச்சி மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கரோலினா சிறுநீரக ஆராய்ச்சி மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கரோலினா சிறுநீரக ஆராய்ச்சி மையம் Today - Breaking & Trending Today

Arquer Diagnostics' ADXBLADDER Becomes First Bladder Cancer Urine Test To Undergo Rigorous Clinical Trials In USA


Arquer Diagnostics ADXBLADDER Becomes First Bladder Cancer Urine Test To Undergo Rigorous Clinical Trials In USA
First patients recruited for bladder cancer recurrence monitoring study
News provided by
Share this article
SUNDERLAND, England, July 27, 2021 /PRNewswire/
ADXBLADDER has become the first new generation urinary biomarker test for bladder cancer to undergo rigorous clinical trials in the USA in decades. The innovative and highly accurate test, developed by UK company Arquer Diagnostics, is already approved for use across Europe.
ADXBLADDER is now being evaluated in a bladder cancer recurrence monitoring study in the US. With results of the study expected by the end of 2021, Arquer Diagnostics hopes to make a 510(k) premarket submission to the US Food and Drug Administration (FDA) to gain clearance from the organisation for ....

United States , United Kingdom , Aashish Kamat , Jacqui Stockley , European Association Of Urology , Oncology Trial Management Organisation , National Cancer Institute Comprehensive Center , Drug Administration , Karmanos Cancer Institute Wayne State University , Md Anderson Cancer Center , Cancer Research , Carolina Urologic Research Centre , American Cancer Society , Arquer Diagnostics , Chief Scientific Officer , Minichromosome Maintenance Complex Component , Uro Oncology Trial Management Organisation , Karmanos Cancer , Wayne State University , European Association , Negative Predictive Value , Positive Predictive Value , Urologic Oncology , Cancer Center , Neal Shore , Medical Director ,

Prostate Cancer Screenings on the Decline with Concerns Surrounding COVID-19: What Men Should Know


Sponsored Story
By StoryStudio April 1, 2021 4:35 pm
(BPT) – In the early part of the COVID-19 pandemic, many areas of the country banned nonessential medical procedures in an effort to slow the spread of the disease. As a result, many physicians saw fewer patients for routine medical care, such as physical exams and screenings. A recent survey by The Physicians Foundation polled 3,513 physicians and found 41% saw volume decreases of 26% or more in their practices.
The impact on cancer screenings was even more profound. For example, screenings for prostate cancer one of the most commonly diagnosed cancers in men in the United States dropped by 56% by the peak of the pandemic in April according to a recent study published in ....

United States , American Society Of Clinical Oncology , National Cancer Institute , America Physicians , Carolina Urologic Research Center , Drug Administration , National Cancer Institute Surveillance , End Results Program , Physicians Foundation , American Cancer Society , Neal Shore , Medical Director , Carolina Urologic Research , Posterior Reversible Encephalopathy Syndrome , Important Safety Information , Reversible Encephalopathy Syndrome , Patient Information , Full Prescribing Information , Cancer Inform , Prostate Cancer , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கன் சமூகம் ஆஃப் மருத்துவ புற்றுநோயியல் , தேசிய புற்றுநோய் நிறுவனம் , அமெரிக்கா மருத்துவர்கள் , கரோலினா சிறுநீரக ஆராய்ச்சி மையம் , தேசிய புற்றுநோய் நிறுவனம் கண்காணிப்பு ,